Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia

References

• Biondi A, Cimino G, Pieters R, Pui C H. Biological and therapeutic aspects of infant leukemia. Blood 2000; 96: 24–33
   PubMed Web of Science ®Google Scholar
• Pui C H, Chessells J M, Camitta B, Baruchel A, Biondi A, Boyett J M, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003; 17: 700–706
   PubMed Web of Science ®Google Scholar
• Cimino G, Rapanotti M C, Rivolta A, Lo C F, D'Arcangelo E, Rondelli R, et al. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia 1995; 9: 391–395
   PubMed Web of Science ®Google Scholar
• Pui C H, Gaynon P S, Boyett J M, Chessells J M, Baruchel A, Kamps W, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909–1915
   PubMed Web of Science ®Google Scholar
• Biondi A, Rizzari C, Valsecchi M G, de L P, Arico M, Basso G, et al. Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica 2006; 91: 534–537
   PubMed Web of Science ®Google Scholar
• Chessells J M, Harrison C J, Watson S L, Vora A J, Richards S M. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999. Br J Haematol 2002; 117: 306–314
   PubMed Web of Science ®Google Scholar
• Pieters R, Schrappe M, de L P, Hann I, De R G, Felice M, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240–250
   PubMed Web of Science ®Google Scholar
• Pui C H, Ribeiro R C, Campana D, Raimondi S C, Hancock M L, Behm F G, et al. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 1996; 10: 952–956
   PubMed Web of Science ®Google Scholar
• Satake N, Maseki N, Nishiyama M, Kobayashi H, Sakurai M, Inaba H, et al. Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants. Leukemia 1999; 13: 1013–1017
   PubMed Web of Science ®Google Scholar
• Armstrong S A, Staunton J E, Silverman L B, Pieters R, den Boer M L, Minden M D, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41–47
   PubMed Web of Science ®Google Scholar
• Fine B M, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004; 103: 1043–1049
   Google Scholar
• Gilliland D G, Griffin J D. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532–1542
   PubMed Web of Science ®Google Scholar
• Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, et al. Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911–1918
   PubMed Web of Science ®Google Scholar
• Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H, et al. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 1998; 12: 1333–1337
   PubMed Web of Science ®Google Scholar
• Scheijen B, Griffin J D. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 2002; 21: 3314–3333
   PubMed Web of Science ®Google Scholar
• Abu-Duhier F M, Goodeve A C, Wilson G A, Care R S, Peake I R, Reilly J T. Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. Br J Haematol 2001; 113: 983–988
   PubMed Web of Science ®Google Scholar
• Meshinchi S, Alonzo T A, Stirewalt D L, Zwaan M, Zimmerman M, Reinhardt D, et al. Clinical implications of FLT3 mutations in pediatric AML. Blood 2006; 108: 3654–3661
   PubMed Web of Science ®Google Scholar
• Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326–4335
   PubMed Web of Science ®Google Scholar
• Xu F, Taki T, Yang H W, Hanada R, Hongo T, Ohnishi H, et al. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children. Br J Haematol 1999; 105: 155–162
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434–2439
   PubMed Web of Science ®Google Scholar
• Xu F, Taki T, Eguchi M, Kamada N, Ishii E, Endo M, et al. Tandem duplication of the FLT3 gene is infrequent in infant acute leukemia. Japan Infant Leukemia Study Group. Leukemia 2000; 14: 945–947
   PubMed Web of Science ®Google Scholar
• Armstrong S A, Kung A L, Mabon M E, Silverman L B, Stam R W, den Boer M L, et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 2003; 3: 173–183
   PubMed Web of Science ®Google Scholar
• Armstrong S A, Mabon M E, Silverman L B, Li A, Gribben J G, Fox E A, et al. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood 2004; 103: 3544–3546
   PubMed Web of Science ®Google Scholar
• Taketani T, Taki T, Sugita K, Furuichi Y, Ishii E, Hanada R, et al. FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood 2004; 103: 1085–1088
   PubMed Web of Science ®Google Scholar
• Stam R W, den Boer M L, Schneider P, Meier M, Beverloo H B, Pieters R. D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia. Haematologica 2007; 92: 1565–1568
   PubMed Web of Science ®Google Scholar
• Pombo-de-Oliveira M S, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 2006; 15: 2336–2341
   PubMed Web of Science ®Google Scholar
• Emerenciano M, Agudelo Arias D P, Coser V M, Brito G D, Macedo Silva M L, Pombo-de-Oliveira M S. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. Pediatr Blood Cancer 2006; 47: 549–554
   PubMed Web of Science ®Google Scholar
• Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002; 100: 59–66
   PubMed Web of Science ®Google Scholar
• Stam R W, den Boer M L, Schneider P, Nollau P, Horstmann M, Beverloo H B, et al. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia. Blood 2005; 106: 2484–2490
   PubMed Web of Science ®Google Scholar
• Howard S C, Pedrosa M, Lins M, Pedrosa A, Pui C H, Ribeiro R C, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 26: 2471–2475
   Web of Science ®Google Scholar
• Ribeiro K B, Lopes L F, de Camargo B. Trends in childhood leukemia mortality in Brazil and correlation with social inequalities. Cancer 2007; 110: 1823–1831
   PubMed Web of Science ®Google Scholar